We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMB icon
251
Williams Companies
WMB
$85.8B
$9.57M 0.08%
423,768
– –
NTLA icon
252
Intellia Therapeutics
NTLA
$1.51B
$9.56M 0.08%
182,917
– –
QSR icon
253
Restaurant Brands International
QSR
$26.2B
$9.5M 0.08%
161,949
– –
BNY
254
Bank of New York Mellon
BNY
$103B
$9.47M 0.08%
232,242
-4
-0% -$176
SWTX
255
DELISTED
SpringWorks Therapeutics
SWTX
$9.47M 0.08%
135,879
-1
-0% -$78
HIG icon
256
Hartford Financial Services
HIG
$39.9B
$9.39M 0.08%
199,656
– –
OKE icon
257
Oneok
OKE
$56.7B
$9.36M 0.08%
227,174
– –
ATO icon
258
Atmos Energy
ATO
$29.7B
$9.35M 0.08%
102,039
+2
+0% +$182
BAX icon
259
Baxter International
BAX
$12.8B
$9.35M 0.08%
121,346
– –
ALLK
260
DELISTED
Allakos
ALLK
$9.27M 0.08%
68,951
– –
KMI icon
261
Kinder Morgan
KMI
$70.9B
$9.27M 0.08%
705,671
– –
IGMS
262
DELISTED
IGM Biosciences
IGMS
$9.23M 0.08%
108,892
– –
WDAY icon
263
Workday
WDAY
$41.5B
$9.09M 0.08%
39,472
– –
STT icon
264
State Street
STT
$48.4B
$9.08M 0.08%
129,832
– –
AXSM icon
265
Axsome Therapeutics
AXSM
$11.7B
$9.06M 0.08%
115,802
– –
INSM icon
266
Insmed
INSM
$22.4B
$9.05M 0.08%
282,901
– –
BRK.B icon
267
Berkshire Hathaway Class B
BRK.B
$1.1T
$8.84M 0.07%
39,765
– –
KSU
268
DELISTED
Kansas City Southern
KSU
$8.72M 0.07%
44,450
– –
EPAM icon
269
EPAM Systems
EPAM
$5.58B
$8.71M 0.07%
25,300
– –
HAS icon
270
Hasbro
HAS
$13.5B
$8.69M 0.07%
96,727
– –
HMSY
271
DELISTED
HMS Holdings Corp.
HMSY
$8.68M 0.07%
245,943
– –
YMAB
272
DELISTED
Y-mAbs Therapeutics
YMAB
$8.56M 0.07%
179,945
-1
-0% -$41
ARDX icon
273
Ardelyx
ARDX
$1.24B
$8.53M 0.07%
1,372,217
– –
CIXX
274
DELISTED
CI Financial Corp.
CIXX
$8.53M 0.07%
716,686
– –
BKR icon
275
Baker Hughes
BKR
$58.3B
$8.44M 0.07%
421,457
– –
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.